In March 2014, Siemens officially presented Unity 3, the latest version of their diagnostic and fitting system for hearing care professionals. Presented at at the American Academy of Audiology's AudiologyNOW! conference in Orlando, Florida, The system combines all of the hearing care professional’s work steps in a single, time-saving process: from computer-assisted hearing ability measurement to the individual fitting of the selected hearing aids.
ResMed, the industry leader in patient-comfort innovation, today introduced its new AirSense™ 10 positive-airway pressure (PAP) device platform, with breakthrough features that benefit both the patient and the healthcare provider.The AirSense 10 series PAP devices are the cornerstones of the ResMed Air Solutions connected care platform, an ecosystem of hardware and software solutions that can significantly streamline the patient compliance monitoring and management process while improving overall patient outcomes and engagement.
Caris Life Sciences, a leading biosciences company focused on fulfilling the promise of precision medicine, today announced a collaboration with GenoSpace, a Massachusetts-based technology company that develops robust software solutions for genomic and health data. Caris will apply GenoSpace's population analytics offerings to uncover and better utilize key insights from the company's industry-leading tumor profiling service, Caris Molecular Intelligence™.
HeartGLO Inc., a health technology and integrative wellness company, based in San Francisco, is doing something completely new when it comes to health & wellness tracking. It is putting the user in the power seat by offering the first comprehensive health management app that not only lets users track, but also shows them how to manage their daily health to live well sustainably. HeartGLO does this through a set of well-established wellness practices that cover Nutrition, Sleep, Activity, Stress, Meditation, and Conscious Breathing.
Forty-five percent of normal adults snore at least occasionally and 25 percent are habitual snorers.1 Theravent® Advanced Nightly Snore Therapy is the first and only FDA-cleared Expiratory Positive Airway Pressure (EPAP) therapy designed to reduce or eliminate snoring. Since 2012, Theravent REGULAR strength has surpassed over one million quiet nights of sleep for snorers and their bed partners. Beginning today, Theravent LITE and Theravent MAX are available, offering two new clinically proven options to reduce and eliminate snoring.
Covaris, Inc. announced the introduction of the patent-pending microTUBE LV, its latest product designed for low volume, high performance DNA Shearing for Next Generation Sequencing (NGS) applications. The Covaris microTUBE LV allows researchers to process samples as small as 15 microliters using Adaptive Focused Acoustics (AFA™) which has become the "gold standard" in genome research and clinical centers worldwide.
Toshiba is proud to introduce "SURESubtraction™ Coronary". This software was developed in close cooperation with the Iwate Medical University in Japan, leading hospitals in the USA and Europe and the European based research center, Toshiba Medical Visualization Systems. Visualization of the coronary lumen is improved by very advanced subtraction software. This represents a major step forward in diagnosing coronary artery disease in patients with severe calcium or stents for whom Cardiac CT Angiography was not recommended.
As high-precision miniature tools from nature, enzymes can solve certain tasks perfectly. The search for new industrial usable enzyme functions is very complex. A project of the Austrian Centre of Industrial Biotechnology and the University of Graz opens up a new approach: The Catalophor System - a combination of database and search engine - filters desired enzyme functions out of tens of thousands of protein structure data and can even track functionalities that have not been discovered yet.
ResMed today announced Air Solutions, a new forward-thinking connected care solution for treating sleep-disordered breathing that can benefit all stakeholders in the care continuum. The ResMed Air Solutions platform has data-driven components that span from diagnosis to treatment, compliance management and patient engagement.
Royal Philips announced that, for a second year in a row, customers have named Philips Healthcare as the overall Best in KLAS Imaging Equipment Company in the 2014 Best in KLAS Awards: Medical Equipment & Infrastructure report. Philips also received Best in KLAS honors for three products in MR and Ultrasound.
With acne as the most common skin condition affecting more than 60 million Americans today, it is no surprise that 20 million people have severe enough acne to cause scarring (33 percent of sufferers). Cynosure, the leader in aesthetic lasers, announced today that PicoSure is the first and only picosecond laser now FDA-cleared to treat acne scars.
Oncolab, the Boston-based laboratory which has developed the AMAS cancer test, is making its AACC debut (booth #4051) at this year's conference in Chicago. To date, the test has been run for over 60,000 patients and is emerging as a significant tool in the fight against cancer recurrence.
Envarsus® Receives European Marketing Authorization for Treatment of Both Kidney and Liver Transplant Patients
Veloxis Pharmaceuticals and Chiesi Farmaceutici today announced that the European Commission has granted marketing authorization for Envarsus® for the prevention of organ rejection in adult kidney and liver transplant patients in the European Union.
Page 1 of 2